Albemarle (ALB)
(Delayed Data from NYSE)
$89.33 USD
+2.74 (3.16%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $89.33 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Albemarle Corporation [ALB]
Reports for Purchase
Showing records 161 - 180 ( 786 total )
Company: Albemarle Corporation
Industry: Chemical - Diversified
Optimized Entry and Exit Levels for ALB 71122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Optimized Entry and Exit Levels for ALB 7122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Optimized Entry and Exit Levels for ALB 62122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Optimized Entry and Exit Levels for ALB 61122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Optimized Entry and Exit Levels for ALB 6122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
Comprehensive Technical and Fundamental Analysis for ALB.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
1Q22 Follow-Up - Price Execution Improves Markedly
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Company: Albemarle Corporation
Industry: Chemical - Diversified
1Q22 First Look - Lithium Price Drives 50% Guidance Raise
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Albemarle Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department